IRF7 and systemic sclerosis: Of interest, Wu et al. (2019) have reported that IRF7 bridges inflammation to fibrogenesis by interacting with SMAD3, a key mediator of TGF-β signaling and that IRF7 knockout mice are protected from systemic sclerosis, a prototypical form of inflammation-associated tissue fibrosis.